8,20 Kidney disease is one of the most clinically morbid consequences of ANCA vasculitis. The prevalence of renal involvement varies according to subtype, occurring in about 90% of patients with ...

Treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and renal disease with the oral C5a receptor inhibitor avacopan (Tavneos, ChemoCentryx) provides significant ...

We randomly assigned, in a 3:1 ratio, 44 patients with newly diagnosed ANCA-associated vasculitis and renal involvement to a standard glucocorticoid regimen plus either rituximab at a dose of 375 ...

Swedish investigators report high 1-year rates of renal and patient survival. Patients who have ANCA-associated vasculitis (AAV) with renal involvement have high short-term overall rates of renal ...

Investigators compared myeloperoxidase and PR3 ANCA-associated vasculitis. Renal prognoses are better in patients with PR3 ANCA-associated vasculitis (AAV) than myeloperoxidase (MPO) AAV ...

Most children with ANCA-associated vasculitis had active kidney disease and impaired renal function at diagnosis. Those with normal or minimal kidney impairment had good chance of recovery.

“ANCA-associated vasculitis is associated with increased early mortality and a high risk of end-stage renal disease,” Peter A. Merkel, MD, MPH, chief of rheumatology and a professor of ...

June 2, 2009 (Milan, Italy) — Renal vasculitis associated with antineutrophil cytoplasm antibody (ANCA) is typically treated with cyclophosphamide, which is effective in 90% of cases but can be ...

ANCA vasculitis can affect blood vessels in ... or cough (lung vasculitis) High blood pressure (kidney vasculitis) Get emergency medical help right away if you have chest pressure or new or ...

BASEL, Switzerland--(BUSINESS WIRE)--Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis ...